EP 0474453 A3 19920422 - PHARMACEUTICAL COMPOSITION COMPRISING AN ACTIVE PEPTIDE OR PROTEIN AND A HEAT-LABILE ENTEROTOXIN B AND ITS MUCOUS USE
Title (en)
PHARMACEUTICAL COMPOSITION COMPRISING AN ACTIVE PEPTIDE OR PROTEIN AND A HEAT-LABILE ENTEROTOXIN B AND ITS MUCOUS USE
Publication
Application
Priority
JP 23430390 A 19900903
Abstract (en)
[origin: EP0474453A2] A pharmaceutical composition containing a physiologically active peptide or protein which is poorly absorbable through the gastrointestinal tract and heat-labile enterotoxin B subunit brings an increased absorbability of said peptide or protein into the mammalian body when administered through mucous.
IPC 1-7
IPC 8 full level
A61K 9/00 (2006.01); A61K 38/04 (2006.01); A61K 38/17 (2006.01); A61K 47/42 (2006.01); C07K 14/245 (2006.01)
CPC (source: EP US)
A61K 9/0043 (2013.01 - EP US); A61K 38/04 (2013.01 - EP US); A61K 38/17 (2013.01 - EP US); A61K 47/42 (2013.01 - EP US); C07K 14/245 (2013.01 - EP US); Y02A 50/30 (2017.12 - EP US)
Citation (search report)
- EP 0418626 A2 19910327 - TAKEDA CHEMICAL INDUSTRIES LTD [JP]
- EP 0416505 A2 19910313 - TAKEDA CHEMICAL INDUSTRIES LTD [JP]
- WO 8606635 A1 19861120 - BIOTECH AUSTRALIA PTY LTD [AU]
Designated contracting state (EPC)
AT BE CH DE DK ES FR GB GR IT LI LU NL SE
DOCDB simple family (publication)
EP 0474453 A2 19920311; EP 0474453 A3 19920422; CA 2050425 A1 19920304; US 5554378 A 19960910
DOCDB simple family (application)
EP 91308038 A 19910902; CA 2050425 A 19910830; US 37911495 A 19950127